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Fig. S1. Schematic diagram of optimized INFOGEST 2.0 simulated in vitro digestion protocol 2 
2.1. Camel milk (CM) samples preparation 3 
Fresh raw CM was purchased from a local farm in Al-Ain (UAE) and stored at 4°C. Fresh milk 4 
was concentrated using a pilot unit vacuum evaporator (Model FT22, Armfield Ltd, UK). The 5 
concentrated CM was dried using a pilot model spray dryer (Model FT80, Armfield Ltd, UK). The 6 
spray dryer had a co- or counter-current flow configuration with a maximum water evaporation 7 
rate of 3 l/h, the twin fluid pressure nozzle atomizer was used. The inlet temperature was set at 8 
190°C. The flow rate of the feed stock was tested at 5 l/h. This spray dried CM (SDCM) was used 9 
as control for the simulated in vitro digestion protocol.  10 
Freeze dried (lyophilized) CM (FDCM) was prepared by using a pilot-scale freeze dryer. The 11 
concentrated CM was lyophilized at −15 °C for 24 h then freeze dried at −80 °C for four weeks 12 
under 0.05 mbar. The FDCM powder was then stored at + 4 °C until further analysis. 13 
2.1.1. Fruit juice fortified CM powder preparation  14 
The whole CM and fresh fruit juice (grape and pomegranate, commercial pasteurized juices 15 
purchased from local supermarket, free of added sugar, artificial colors and preservatives) were 16 
concentrated using a vacuum rising film evaporator (40° C to 50° C) to obtain a concentrate with 17 
a concentration of 28% and 45 % total solids respectively. The concentrated camel’s milk and the 18 
concentrated fruit juice were heated and then blended to uniformity in an agitated vessel (at a 19 
temperature between 40° C and 50° C). The blended mixture was dried using a pilot spray dryer 20 
to provide a homogenous, powdered fortified dairy product. The inlet temperature of the spray 21 
dryer was in the range of 130° C to 150° C (for few seconds) to preserve the vitamins and heat 22 
sensitive substances (US Patent number 20190239527A1). These fortified CM powder were tested 23 
for pH so as to maintain pH between 4.50 to 7.00 (refer to Table 1 and Table 2 in US Patent number 24 
20190239527A1) along with various physico-chemical properties such as water activity, bulk 25 
density, angle of repose, moisture content, protein and ash content (refer to Table 3, 4 and 5 in US 26 
Patent number 20190239527A1). 27 
2.2.1. Fortified CM sample treatment at different pH 28 
The CM protein aggregation and their stability in presence of fruit juice were further monitored at 29 
different pH values 2.0, 4.0 and 7.5. The fortified milk powders were dissolved in appropriate 30 
buffer (pH 2.0 buffer (Gly-HCl 50 mM), pH 4.0 buffer (Acetate buffer 50 mM), pH 7.5 buffer 31 
PBS) to final concentration 50 mg/ml. The pH was checked and adjusted accordingly if necessary. 32 
The latter steps were repeated: the samples were gently rocked at room temperature for 1h, 33 
centrifuged at 13500 rpm for 10 min then both supernatants and pellets were analyzed on SDS 34 
gels. Supernatants were defatted by dichloromethane extraction (1:1 v/v) prior BPA protein assay 35 
and treatment with the electrophoresis buffer.  36 
2.4. Standardized static in-vitro simulation of gastrointestinal digestion  37 
The enzymes: pepsin for gastric digestion and individual intestinal enzymes trypsin and 38 
chymotrypsin activity, bile concentration was determined following the protocol by Brodkorb et 39 
al, 2019. 40 
Oral phase (OP): CM powder and fruit juice fortified CM powder samples were reconstituted to 41 
240 ul in milliQ water then mixed with 240 ul SSF solution. Human salivary α-amylase was not 42 
added to the sample. CaCl2 (2.4 μL, 150 mmol/L) was added separately to avoid precipitation in 43 
stock solution to achieve final concentration of 0.75 mmol/L. The reaction mixture was incubated 44 
for 2 minutes at 37 °C with agitation. All reagents were previously pre-warmed at 37 °C for 5 45 
minutes. Salivary amylase enzyme was not used for oral phase. 46 
Gastric phase (GP): Complete oral phase digesta was then mixed with 480 μL of SGF stock 47 
solution including 3μL of CaCl2 (25 mM) to achieve a final concentration of 75 µM in the 48 
digestion mixture. Porcine pepsin in 10 mM HCl (2500 U/mg, cat#P7012, Sigma-Aldrich) was 49 
added, to achieve a final concentration of 2000 U/mL in the digestion mixture. Gastric lipase 50 
enzyme was not added in gastric phase. The mixture was adjusted to pH 3 with 1 M HCl, then 51 
water was added, such that the final volume of reaction mixture was 960 μL. The reaction mixture 52 
was incubated for 120 minutes at 37 °C with continuous agitation (400 rpm) in thermoshaker. 53 
Control samples were run in parallel: Pepsin enzyme controls at 0’ and 120’ without CM sample 54 
(sample replaced by sand) were also included. Digestion in one replicate tube of each sample was 55 
stopped by addition of 20 μL 48 uM protease inhibitor pepstatin A (Cat #P5318, Sigma Aldrich) 56 
to achieve the final concentration of 1 uM in the final reaction mixture (the other replicate tube 57 
was further continued with the intestinal phase as described below). The samples were centrifuged 58 
at 10,000 g for 20 minutes; the supernatant was separated from pellet (insoluble solids) and both 59 
were immediately frozen at −20 °C. Protein concentration of supernatant was determined using 60 
BCA assay (Thermo Fisher Scientific Inc., Bremen, Germany) after necessary dilutions.  61 
Intestinal phase (IP): The resulting 960 ul of complete gastric digesta was mixed with 960μL of 62 
SIF stock solution including 23μL of CaCl2 (25 mM) to achieve a final concentration of 300 µM 63 
in the digestion mixture. Individual enzymes porcine trypsin (Measured activity was 194.44 64 
TAME U/mg, cat #T0303, Sigma-Aldrich) and -chymotrypsin from bovine pancreas (Measured 65 
activity was 27 BTEE U/mg, Cat #C7762, Sigma-Aldrich) (to obtain final activity ratio of 4:1 in 66 
the digesta) prepared in SIF was added. The bile extract porcine (measured concentration was 256 67 
mM, cat # B8631, Sigma-Aldrich) was prepared in SIF and added to achieve final concentration 68 
of 10mM in the final digesta. The amylase, pancreatic lipase and the colipase enzymes were not 69 
added. The mixture was adjusted to pH 7 with 1 M NaOH, then milliQ water was added, such that 70 
the final volume of reaction mixture was 1920 μL. The reaction mixture was incubated for 120 71 
minutes at 37 °C with continuous agitation (400 rpm) in thermoshaker. Control samples were run 72 
in parallel: trypsin and chymotrypsin enzyme controls at 0’ and 120’ without CM sample (sample 73 
replaced by sand) were also included. The enzyme activity in the final digestion mixture was 74 
stopped by addition of 20 μL of 480 mM AEBSF/Pefabloc SC (Cat #76307, Sigma Aldrich) to 75 
obtain 5 mM final concentration in the reaction mixture. The samples were centrifuged at 10,000 76 
g for 20 minutes; the supernatant was separated from pellets (insoluble solids) and immediately 77 
frozen at −20 °C until further assessment. Protein concentration of supernatant was determined 78 
using BCA assay (Thermo Fisher Scientific Inc., Bremen, Germany) after necessary dilutions. 79 
2.5. Protein profiling by gel electrophoresis  80 
2.5.1. Native electrophoresis and Sodium dodecyl sulphate polyacrylamide gel electrophoresis 81 
(SDS-PAGE) 82 
FDCM and fortified samples: GJ20/80, GJ50/50, PJ20/80, and PJ40/60 prepared with 83 
sodium phosphate buffer for their solubility tests were characterized by native electrophoresis. Just 84 
the supernatants were dissolved in the native electrophoresis buffer (62.5 mM Tris-HCl, pH 6.8, 85 
40% glycerol, 0.01% Bromophenol Blue) prepared according to the Biorad specifications and run 86 
on Mini-PROTEAN Tetra Cell system (Bio-Rad Laboratories) with the native electrophoresis 87 
running buffer (10x Tris/Glycine: 25mM Tris, 192 mM glycine, pH 8.3) according to the Biorad 88 
protocol based on modified Ornstein and Davis 1964 method.  89 
They were also comparatively characterized via SDS-PAGE under both reducing 90 
conditions and non-reducing conditions using 4-20% gradient precast gels (Mini-PROTEAN 91 
TGX, Bio-Rad Laboratories) as explained below. 92 
2.5.2. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 93 
In addition to solubility test, FDCM and fortified samples: GJ20/80, GJ50/50, PJ20/80, and 94 
PJ40/60 prepared with different buffers for their pH stability tests were characterized via SDS-95 
PAGE under both reducing conditions and non-reducing conditions using 4-20% gradient precast 96 
gels (Mini-PROTEAN TGX, Bio-Rad Laboratories). The supernatant and the pellets protein 97 
profile of the samples were acquired for pH test as well as the digestibility studies. SDCM instead 98 
of FDCM was used as the control sample in case of digestibility study. The detailed steps of sample 99 
preparation for the SDS-PAGE are explained below. 100 
For CM protein digestibility study, the protein concentration was determined by 101 
Bicinchoninic acid Assay (BCA) (Smith et al., 1985) in triplicates using Bovine serum albumin 102 
(BSA) as standard then the dilutions were made to maintain uniform protein concentration of 1 103 
ug/ul among all the samples. Prior to sample loading, each sample was mixed well with the 104 
respective sample buffer, β-mercaptoethanol was used as a reducing agent with the Laemmli 105 
sample buffer (#1610747, Bio-rad Laboratories) while preparing sample under reducing 106 
conditions. The samples were prepared in the Laemmli sample buffer without β-mercaptoethanol 107 
under non-reducing conditions. The samples were denatured by heating at 95°C for 5 min at 400 108 
rpm on thermoshaker (Thermo Scientific), cooled to room temperature then 20 ug protein was 109 
loaded unto the gel well. The gels were run on Mini-PROTEAN Tetra Cell system (Bio-Rad 110 
Laboratories) following standard protocol: constant voltage of 200V for approximately 34 min. 111 
Precision Plus Protein Dual Xtra standard, 2-250 KDa (#1610377, Bio-rad Laboratories) was used 112 
for the molecular weight determination of the protein bands. Similarly, the pellets were also 113 
solubilized with the Laemmli sample buffer with and without β-mercaptoethanol. Then, 20 ul of 114 
this sample was loaded onto the gel well. After running the gel, they were stained with Coomassie 115 
Blue staining solution followed by destaining to visualize the gel. Gel visualization, image export 116 
and protein bands quantification were completed using Gel documentation unit: Chemidoc™ 117 
XRS+ and Image lab software version 6.0 (Bio-Rad Laboratories). 118 
3.2. Aggregability study of the soluble CM proteins by size exclusion chromatography (SE-119 
UHPLC) 120 
 121 
Fig. S2. Ultra-High Performance size exclusion chromatography(SE-UHPLC) chromatograms of 122 
fortified camel milk powder samples in the order from FDCM as control (top), GJ20/80, GJ50/50, 123 
PJ20/80, PJ40/60 (bottom). 124 
3.4.1. 1-D Gel Electrophoresis for fortified CM protein digestibility study in supernatant (soluble 125 
fraction) 126 
 127 
Fig S3. The total protein concentration in reconstituted fortified CM samples before simulated in 128 
vitro digestion based on Bicinchoninic Acid Assay (BCA). [The protein concentrations were 129 
determined in triplicates] FDCM: Freeze dried Camel milk as control, GJ20/80: Grape Juice 130 
fortified CM at 20:80 ratio, GJ50/50: Grape Juice fortified CM at 50:50 ratio, PJ20/80: 131 
Pomegranate Juice fortified CM at 20:80 ratio, PJ40/60: Pomegranate Juice fortified CM at 40:60 132 
ratio. 133 
3.3. Gel Electrophoresis of fortified CM protein  134 
 135 
Fig. S4. SDS-PAGE electropherogram of pellets (insoluble protein) of fortified CM powder 136 
samples under reducing and nonreducing conditions at varying pH. FDCM: Freeze dried Camel 137 
milk as control, GJ20/80: Grape Juice fortified CM at 20:80 ratio, GJ50/50: Grape Juice fortified 138 
CM at 50:50 ratio, PJ20/80: Pomegranate Juice fortified CM at 20:80 ratio, PJ40/60: Pomegranate 139 
Juice fortified CM at 40:60 ratio, Std: Biorad precision plus protein standard. 140 
Supplementary Tables  141 
Table S1. Stock solutions preparation of simulated digestive fluids for 125 ml (4x concentration) 142 
of SSF, Simulated Salivary Fluid; SGF, Simulated Gastric Fluid and 250 ml (2x concentration) of 143 
SIF, Simulated Intestinal Fluid. OP, Oral phase; GP, Gastric phase; IP, Intestinal phase  144 
Constituent SSF stock salt 
concentration (mM) 
SGF stock salt 
Concentration (mM) 
SIF stock salt 
Concentration (mM) 
KCl 15.1 6.9 6.8 
KH2PO4 3.7 0.9 0.8 
NaHCO3 13.6 25 85 
NaCl - 47.2 38.4 
MgCl2 (H2O)6 0.15 0.1 0.3 
(NH4)2CO3 0.06 0.5 - 
HCl 1.1 15.6 8.4 
CaCl2(H20)2 1.5 0.15 0.6 
pH 7 3 7 
Note: CaCl2(H20)2 is added immediately before use to avoid the precipitation in stock solutions 145 
during storage.  146 
